INS and diabetes mellitus: Oral hypoglycemic agents: In recently diagnosed drug-naive diabetes patients with fasting blood sugar >200 mg, Gliclazide MR 60 mg was compared to 16 u of premixed insulin, combined with medical nutrition therapy.